Elsevier

Pharmacology & Therapeutics

Volume 172, April 2017, Pages 171-180
Pharmacology & Therapeutics

Associate editor: E. Klussmann
Adenylyl cyclase signalling complexes – Pharmacological challenges and opportunities

https://doi.org/10.1016/j.pharmthera.2017.01.001Get rights and content

Abstract

Signalling pathways involving the vital second messanger, cAMP, impact on most significant physiological processes. Unsurprisingly therefore, the activation and regulation of cAMP signalling is tightly controlled within the cell by processes including phosphorylation, the scaffolding of protein signalling complexes and sub-cellular compartmentalisation. This inherent complexity, along with the highly conserved structure of the catalytic sites among the nine membrane-bound adenylyl cyclases, presents significant challenges for efficient inhibition of cAMP signalling. Here, we will describe the biochemistry and cell biology of the family of membrane-bound adenylyl cyclases, their organisation within the cell, and the nature of the cAMP signals that they produce, as a prelude to considering how cAMP signalling might be perturbed. We describe the limitations associated with direct inhibition of adenylyl cyclase activity, and evaluate alternative strategies for more specific targeting of adenylyl cyclase signalling. The inherent complexity in the activation and organisation of adenylyl cyclase activity may actually provide unique opportunities for selectively targeting discrete adenylyl cyclase functions in disease.

Introduction

The concept that hormones or other cellular regulators act from outside the cell to generate an internal second messenger arose with cAMP. The nucleotide is involved in regulating numerous processes, that can range from fast to slow, or from widespread to highly specialised. It occupies a paradigmatic place in cellular signalling in that, rightly or wrongly, the issues surrounding cAMP signalling became paradigms for how second messenger signalling was to be viewed in general. Thus, the principles established in cAMP signalling either translate directly to other systems or at least they have been assessed in other systems. For example, the cAMP field established phosphorylation and kinases as one of the major covalent devices for regulating cellular activity. Phosphorylation cascades, with their cycles of intertwined feedbacks and feed forwards of phosphorylation and dephosphorylation, are now accepted as the central motif of cellular signalling. Of course, mechanisms for terminating signals are just as important in shaping the nature and range of signals. The scaffolding of numerous signalling proteins is key to the actions and regulation of growth factors and both this concept and its application were readily established for cAMP signalling. In this way, recognition of the organisation inherent in cAMP signalling was a reciprocal benefit from exporting the notion of phosphorylation cascades from the cAMP to growth factor fields. Localism – a consequence of organisation in signalling – may have been proposed by the development of calcium dyes and the elegant organisation of cardiomyocyte calcium signalling, but it is today a directly demonstrable cornerstone feature of cAMP signalling.

Notwithstanding the sixty-year study of cAMP, and the range of processes that cAMP regulates, or perhaps because of the complexity now surrounding cAMP signalling, strategies for interrupting cAMP signalling need to go far beyond the simple level of inhibition of the enzyme that produces the signal, adenylyl cyclase (AC). In this regard cAMP may yet again be pointing the way forward to creative strategies for interfering with general signalling processes. In this review we will address the family of ACs, in terms of their physiological roles, their biochemical and cell biological properties, their organisation and association within the cell, and the nature of cAMP signals. We will assess strategies for interfering with cAMP signalling at these various points in an effort to direct us towards the most fruitful way of addressing the roles of this central second messenger.

Section snippets

Adenylyl cyclases exert complex physiological effects

Cyclic AMP can impact on most significant physiological processes, from regulatory events to metabolism to growth and differentiation. For instance, cAMP has dramatic effects on the regulation of cardiac contractility by the sympathetic nervous system by affecting ion channels and pumps (reviewed in Boularan and Gales, 2015, Efendiev and Dessauer, 2011); it is centrally involved in the control of glycogenolysis and lipolysis (reviewed in Ravnskjaer, Madiraju, & Montminy, 2016), as well as in

Inhibit catalytic activity

ACs catalyse the conversion of a Mg2 +.ATP complex to cAMP, by creating a cyclic phosphodiester bond based on the α-phosphate group of ATP and releasing pyrophosphate (PPi) (Fig. 3). The release of PPi both yields energy for the reaction and it's dissociation is ultimately the rate-limiting step in cAMP production (Dessauer, 2002). As the determinants of nucleotide binding and catalysis are shared between the two catalytic domains (termed C1 and C2), any change in this relative orientation will

Conclusions

The ubiquity of cAMP involvement in regulating numerous physiological processes provides a key opportunity to modulate these events. We have outlined the themes that have evolved to constrain and finetune the actions of cAMP, from the activation of ACs to their selective associations and placement within the cell. The range of elaborate devices that describe cAMP signalling in particular contexts provide potentially unique assemblies that may be amenable to specific perturbation, should

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References (112)

  • R. Efendiev et al.

    AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors

    The Journal of Biological Chemistry

    (2010)
  • G. Gerisch et al.

    Intracellular oscillations and release of cyclic AMP from Dictyostelium cells

    Biochemical and Biophysical Research Communications

    (1975)
  • C. Gu et al.

    Calmodulin-binding sites on adenylyl cyclase type VIII

    The Journal of Biological Chemistry

    (1999)
  • C. Gu et al.

    Persistent interactions between the two transmembrane clusters dictate the targeting and functional assembly of adenylyl cyclase

    Current Biology

    (2001)
  • B.P. Head et al.

    Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components

    The Journal of Biological Chemistry

    (2006)
  • N. Hoshi et al.

    Interaction with AKAP79 modifies the cellular pharmacology of PKC

    Molecular Cell

    (2010)
  • J.H. Hurley

    Structure, mechanism, and regulation of mammalian adenylyl cyclase

    The Journal of Biological Chemistry

    (1999)
  • H. Ju et al.

    Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity

    The Journal of Biological Chemistry

    (1997)
  • M. Kamenetsky et al.

    Molecular details of cAMP generation in mammalian cells: A tale of two systems

    The Journal of Molecular Biology

    (2006)
  • M.S. Kapiloff et al.

    An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes

    The Journal of Biological Chemistry

    (2009)
  • L.R. Landa et al.

    Interplay of Ca2 + and cAMP signaling in the insulin-secreting MIN6 beta-cell line

    The Journal of Biological Chemistry

    (2005)
  • A. Laurenza et al.

    Forskolin: A specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

    Trends in Pharmacological Sciences

    (1989)
  • J. Liou et al.

    STIM is a Ca2 + sensor essential for Ca2 +-store-depletion-triggered Ca2 + influx

    Current Biology

    (2005)
  • J.H. Lorent et al.

    Structural determinants of protein partitioning into ordered membrane domains and lipid rafts

    Chemistry and Physics of Lipids

    (2015)
  • T.-C. Mou et al.

    Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 ′(3′)-O-(N-methylanthraniloyl)-guanosine 5 ′-triphosphate

    The Journal of Biological Chemistry

    (2005)
  • S. Munro

    Lipid rafts: Elusive or illusive?

    Cell

    (2003)
  • R.S. Ostrom et al.

    Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes

    The Journal of Biological Chemistry

    (2004)
  • J.P. Pieroni et al.

    Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6

    The Journal of Biological Chemistry

    (1995)
  • P.E. Rapp et al.

    Oscillations in calcium-cyclic AMP control loops form the basis of pacemaker activity and other high frequency biological rhythms

    Journal of Theoretical Biology

    (1977)
  • R.F.R. Schindler et al.

    The Popeye domain containing protein family - A novel class of cAMP effectors with important functions in multiple tissues

    Progress in Biophysics and Molecular Biology

    (2016)
  • R. Seifert et al.

    Inhibitors of membranous adenylyl cyclases

    Trends in Pharmacological Sciences

    (2012)
  • P.W. Shaul et al.

    Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae

    The Journal of Biological Chemistry

    (1996)
  • T.J. Shuttleworth

    Arachidonic acid, ARC channels, and Orai proteins

    Cell Calcium

    (2009)
  • C. Steegborn

    Structure, mechanism, and regulation of soluble adenylyl cyclases - Similarities and differences to transmembrane adenylyl cyclases

    Biochimica et Biophysica Acta

    (2014)
  • P.J.S. Stork et al.

    Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

    Trends in Cell Biology

    (2002)
  • M. Szaszák et al.

    Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells

    Cellular Signalling

    (2008)
  • M. Thangavel et al.

    The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae

    Cellular Signalling

    (2009)
  • H. Tu et al.

    Association of type 1 inositol 1,4,5-trisphosphate receptor with AKAP9 (Yotiao) and protein kinase A

    The Journal of Biological Chemistry

    (2004)
  • M. Vig et al.

    CRACM1 multimers form the ion-selective pore of the CRAC channel

    Current Biology

    (2006)
  • L.J. Ayling et al.

    Adenylyl cyclase AC8 directly controls its micro-environment by recruiting the actin cytoskeleton in a cholesterol-rich milieu

    Journal of Cell Science

    (2012)
  • S. Beltz et al.

    Regulation by the quorum sensor from Vibrio indicates a receptor function for the membrane anchors of adenylates cyclases

    eLife

    (2016)
  • G. Borland et al.

    EPAC proteins transduce diverse cellular actions of cAMP

    British Journal of Pharmacology

    (2009)
  • C. Boularan et al.

    Cardiac cAMP: Production, hydrolysis, modulation and detection

    Frontiers in Pharmacology

    (2015)
  • C.A. Bravo et al.

    A food and drug administration-approved antiviral agent that inhibits adenylyl cyclase type 5 protects the ischemic heart even when administered after reperfusion

    Journal of Pharmacology and Experimental Therapeutics

    (2016)
  • A. Brouet et al.

    Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins

    Circulation Research

    (2001)
  • D.M.F. Cooper et al.

    Adenylate cyclase-centred microdomains

    The Biochemical Journal

    (2014)
  • A.J. Crossthwaite et al.

    A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A

    Molecular Pharmacology

    (2006)
  • M.A. Davare et al.

    A beta2 adrenergic receptor signaling complex assembled with the Ca2 + channel Cav1.2

    Science

    (2001)
  • T.A. Dunn et al.

    Imaging of cAMP levels and protein kinase A activity reveals that retinal waves drive oscillations in second-messenger cascades

    Journal of Neuroscience

    (2006)
  • O. Dyachok et al.

    Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells

    Nature

    (2006)
  • Cited by (68)

    • Pathological changes in GPCR signal organisation: Opportunities for targeted therapies for triple negative breast cancer

      2023, Pharmacology and Therapeutics
      Citation Excerpt :

      Lipids play an important organisational role in membranes, and lipid-protein interactions are essential for the formation of organised signalling domains (Balla, 2005; Ostrom & Insel, 2004). Moreover, the interplay between cAMP and calcium signalling pathways can be driven by the organisation of protein complexes featuring scaffolding proteins (AKAPs), ACs and calcium channels (Efendiev & Dessauer, 2011; Halls & Cooper, 2017; Willoughby et al., 2012). For example, the Orai1/STIM1 calcium channels are upregulated in TNBC (Makena & Rao, 2020) and can facilitate tumour cell invasion (Monteith, Prevarskaya, & Roberts-Thomson, 2017).

    • Vascular Ca<inf>V</inf>1.2 channels in diabetes

      2022, Current Topics in Membranes
    • Isoforskolin, an adenylyl cyclase activator, attenuates cigarette smoke-induced COPD in rats

      2021, Phytomedicine
      Citation Excerpt :

      Thus, ISOF may inhibit mTOR via cAMP/PKA signaling. The role of specific AC isoforms in human diseases is just beginning to emerge, and finding AC isoform-selective stimulator or inhibitor compounds is challenging (Dessauer et al., 2017; Halls and Cooper, 2017; Pinto et al., 2008). Previous research showed that the unselective AC activator forskolin could induce bronchodilatation in patients with asthma (Pierre et al., 2009).

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text